Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and fungal deoxyribonucleic acid (DNA) constitutes the essential genetic material for microbial life, encoding all proteins and regulatory elements necessary for cellular function and replication (NIH, 2023). In bacteria, DNA is typically organized into a single circular chromosome and various plasmids, while fungal DNA is organized into linear chromosomes within a nucleus, similar to eukaryotes but with distinct regulatory sequences (Wikipedia, 2024). As a therapeutic target, microbial DNA is susceptible to agents that cause direct physical damage, such as strand breaks or cross-links, which halt the cell cycle and lead to microbial death (StatPearls, 2023). For example, nitroimidazole antibiotics like metronidazole are reduced within anaerobic bacteria to form reactive radicals that attack the DNA backbone (PubMed, 2022). In fungi, certain antimetabolites like flucytosine are converted into fraudulent nucleotides that incorporate into DNA or inhibit its synthesis, disrupting its integrity and function (DrugBank, 2024). The primary challenge in targeting DNA is achieving sufficient selectivity to spare host genomic DNA from similar damage, thereby minimizing the risk of secondary malignancies or organ toxicity (PubMed, 2021).
Induction of DNA strand breaks via reactive intermediates, intercalation between base pairs, and covalent cross-linking of DNA strands to prevent replication and transcription (StatPearls, 2023; NIH, 2024).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and fungal deoxyribonucleic acid (DNA).